Point72 Asset Management
JAZZ icon

Point72 Asset Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Point72 Asset Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$246K Buy
+1,300
New +$227K ﹤0.01% 3445
2024
Q2 		– Sell
-6,000
Closed -$723K – 2146
2024
Q1 		$723K Buy
6,000
+2,000
+50% +$245K ﹤0.01% 1545
2023
Q4 		$492K Buy
+4,000
New +$499K ﹤0.01% 1581

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Point72 Asset Management's JAZZ Position: Q1 2026 in Review

Point72 Asset Management increased its Jazz Pharmaceuticals (JAZZ) stake by 105% in Q1 2026, buying an estimated $32.1M and bringing the position to 358,634 shares worth $67.8M. The position accounts for 0.09% of the portfolio, ranked #271.

Point72 Asset Management first reported a position in JAZZ in Q3 2015 and has held it in 29 quarters since. The position peaked at $123M in Q4 2021. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • Point72 Asset Management held 358,634 shares of Jazz Pharmaceuticals worth $67.8M as of Q1 2026.
  • Point72 Asset Management bought 183,634 Jazz Pharmaceuticals shares in Q1 2026, an estimated $32.1M.
  • Jazz Pharmaceuticals made up 0.09% of Point72 Asset Management's portfolio in Q1 2026, its #271 holding.
  • Point72 Asset Management first reported a position in Jazz Pharmaceuticals in Q3 2015 and has held it in 29 quarters since.
  • Point72 Asset Management's Jazz Pharmaceuticals position peaked at $123M in Q4 2021.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.